Literature DB >> 19247985

Extracellular matrix-polymer hybrid materials produced in a pulsed-flow bioreactor system.

Cecilia Aulin1, Farhad Foroughi, Robert Brown, Jöns Hilborn.   

Abstract

Cell adhesion, interaction with material, cell proliferation and the production of an extracellular matrix (ECM) are all important factors determining the successful performance of an engineered scaffold. Scaffold design should aim at creating structures which can guide cells into forming new, functional tissue. In this study, the concept of in situ deposition of ECM by human dermal fibroblasts onto a compliant, knitted poly (ethyleneterephtalate) support is demonstrated, creating in vitro produced ECM polymer hybrid materials for tissue engineering. Comparison of cells cultured under static and dynamic conditions were examined, and the structure and morphology of the materials so formed were evaluated, along with the amount collagen deposited by the seeded cells. In vitro produced ECM polymer hybrid scaffolds could be created in this way, with the dynamic culture conditions increasing ECM deposition. Histological analysis indicated a homogenous distribution of cells in the 1 mm thick scaffold, surrounded by a matrix-like structure. ECM deposition was observed throughout the materials wigh 81.6 microg/cm(2) of collagen deposited after 6 weeks. Cell produced bundles of ECM fibres bridged the polymer filaments and anchored cells to the support. These findings open hereto unknown possibilities of producing materials with structure designed by engineering together with biochemical composition given by cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19247985     DOI: 10.1002/term.152

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  1 in total

1.  Design of experiments approach to engineer cell-secreted matrices for directing osteogenic differentiation.

Authors:  Martin L Decaris; J Kent Leach
Journal:  Ann Biomed Eng       Date:  2010-12-01       Impact factor: 3.934

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.